Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma. - Mao Y; Gide TN; Maher NG; Vignati D; Boutros A; Cornejo-Páramo P; Potter AJ; Carlino MS; Paver EC; Burke H; Menzies AM; Lo SN; et al. (NPJ precision oncology, 2026)